These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18473146)

  • 1. Prescription tracking and public health.
    Fugh-Berman A
    J Gen Intern Med; 2008 Aug; 23(8):1277-80. PubMed ID: 18473146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical marketing research and the prescribing physician.
    Greene JA
    Ann Intern Med; 2007 May; 146(10):742-8. PubMed ID: 17502635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.
    Khazzaka M
    BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical sales representatives and patient safety: a comparative prospective study of information quality in Canada, France and the United States.
    Mintzes B; Lexchin J; Sutherland JM; Beaulieu MD; Wilkes MS; Durrieu G; Reynolds E
    J Gen Intern Med; 2013 Oct; 28(10):1368-75. PubMed ID: 23558775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of pharmaceutical promotion on prescribers in Jordan.
    Altawalbeh SM; Ibrahim IA; Al-Shatnawi SF
    Int J Clin Pharm; 2020 Apr; 42(2):744-755. PubMed ID: 32140917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of pharmaceutical marketing mix strategies on physicians' prescribing behaviors in public and private hospitals, Dessie, Ethiopia: a mixed study design.
    Hailu AD; Workneh BD; Kahissay MH
    BMC Public Health; 2021 Jan; 21(1):65. PubMed ID: 33413248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact Of Academic Medical Center Policies Restricting Direct-To-Physician Marketing On Opioid Prescribing.
    Eisenberg MD; Stone EM; Pittell H; McGinty EE
    Health Aff (Millwood); 2020 Jun; 39(6):1002-1010. PubMed ID: 32479218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct-to-consumer marketing of prescription drugs: creating consumer demand.
    Hollon MF
    JAMA; 1999 Jan; 281(4):382-4. PubMed ID: 9929096
    [No Abstract]   [Full Text] [Related]  

  • 9. Reconciling a "pleasant exchange" with evidence of information bias: A three-country study on pharmaceutical sales visits in primary care.
    Reynolds E; Guénette L; Lexchin J; Cassels A; Wilkes MS; Durrieu G; Beaulieu MD; Mintzes B
    Health Policy; 2018 Mar; 122(3):250-255. PubMed ID: 29395543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical opioid marketing and physician prescribing behavior.
    Beilfuss S; Linde S
    Health Econ; 2021 Dec; 30(12):3159-3185. PubMed ID: 34562329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicians' decision process for drug prescription and the impact of pharmaceutical marketing mix instruments.
    Campo K; De Staebel O; Gijsbrechts E; van Waterschoot W
    Health Mark Q; 2005; 22(4):73-107. PubMed ID: 16597584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of pharmaceutical companies' marketing mix strategies on physicians prescribing practices in Jordan: a cross-sectional study.
    Al Thabbah DH; Almahairah MS; Naser AY; Alrawashdeh HM; Araidah M
    BMC Health Serv Res; 2022 Oct; 22(1):1293. PubMed ID: 36303214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of physicians' participation in non-interventional post-marketing studies on their prescription habits: A retrospective 2-armed cohort study in Germany.
    Koch C; Schleeff J; Techen F; Wollschläger D; Schott G; Kölbel R; Lieb K
    PLoS Med; 2020 Jun; 17(6):e1003151. PubMed ID: 32589633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare beneficiaries and free prescription drug samples: a national survey.
    Tjia J; Briesacher BA; Soumerai SB; Pierre-Jacques M; Zhang F; Ross-Degnan D; Gurwitz JH
    J Gen Intern Med; 2008 Jun; 23(6):709-14. PubMed ID: 18365289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Pharmaceutical Industry Marketing of Opioid Products With Mortality From Opioid-Related Overdoses.
    Hadland SE; Rivera-Aguirre A; Marshall BDL; Cerdá M
    JAMA Netw Open; 2019 Jan; 2(1):e186007. PubMed ID: 30657529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of german physicians in private practice about contacts with pharmaceutical sales representatives.
    Lieb K; Brandtönies S
    Dtsch Arztebl Int; 2010 Jun; 107(22):392-8. PubMed ID: 20574555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescriber profiling.
    Kirk SM
    Ann Intern Med; 2008 Jan; 148(1):82. PubMed ID: 18166766
    [No Abstract]   [Full Text] [Related]  

  • 19. Prescriber profiling.
    Fugh-Berman A
    Ann Intern Med; 2008 Jan; 148(1):82. PubMed ID: 18166765
    [No Abstract]   [Full Text] [Related]  

  • 20. Prescriber profiling.
    Tsai AC
    Ann Intern Med; 2008 Jan; 148(1):81. PubMed ID: 18166763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.